Vaccine Information Statements |
|
|
|
|
|
Up-to-date translations |
|
|
|
| You
are encouraged to distribute the current English version
at the same time as the translation. |
|
| |
|
|
|
|
| |
Out-of-date translations |
|
|
|
| The translations for
some VISs on our website are from previously published English-language
versions that have since been updated. Unfortunately, IAC is not always
able to obtain translations as updates are issued. Please ensure that your
patients receive information consistent with the current of
the following VISs. |
|
|
| POLISH TRANSLATION OF THE DECEMBER 16, 1998 CHICKENPOX VIS |
|
|
|
|
|
|
| This translation does not contain the following
CDC updates: |
|
| • |
|
Section 1: The answer has been rewritten by CDC. |
|
|
|
| • |
|
Section 2: There are now 2 doses; the first dose is 12-15 months and the second dose is 4-6 years. |
|
|
|
| • |
|
CDC added information on MMRV. |
|
|
|
| • |
|
The URL for Vaccine Adverse Event Reporting System (VAERS) has changed. |
|
|
|
| • |
|
The URL for the National Vaccine Injury Compensation Programs has changed. |
|
|
|
| POLISH TRANSLATION OF THE AUGUST 25, 1998 HEPATITIS A VIS |
|
|
|
|
|
|
| This translation does not contain the following
CDC updates: |
|
| • |
|
CDC changed the indication to 1 year or older and has recommended routine use for children. |
|
|
|
| • |
|
Section 2: Added persons who work with primates or in research labs to indications (routine vaccination). |
|
|
|
| • |
|
Added bullet for "persons who live in communities that have prolonged outbreaks of hepatitis A." |
|
|
|
| • |
|
Divided the section into "Who" and "When" parts. |
|
|
|
| • |
|
Removed southern Europe from list of regions with high rates of hepatitis A. |
|
|
|
| • |
|
Section 3: Added bullet about allergy to vaccine component. |
|
|
|
| • |
|
Changed wording, particularly the statement on pregnancy, and made list into bullets. |
|
|
|
| • |
|
Minor changes to part 4, 5, and 6 to be consistent with other recent VISs. |
|
|
|
| • |
|
Removed the section on immune globulin. |
|
|
|
| POLISH TRANSLATION OF THE JULY 11, 2001 HEPATITIS B VIS |
|
|
|
|
|
|
| This translation does not contain the following
CDC updates: |
|
| • |
|
On July 18, the CDC posted an interim VIS for hepatitis B. There are minor changes throughout, but the main purpose of the update is to emphasize the birth dose for all children. |
|
|
|
| • |
|
A final version will be developed. |
|
|
|
| POLISH TRANSLATION OF THE DECEMBER 16, 1998 MMR VIS |
|
|
|
|
|
|
| This translation does not contain the following
CDC updates: |
|
| • |
|
Female patients are now advised to postpone pregnancy for 4 weeks after receiving MMR vaccine (version 12/16/98 read "3 months") |
|
|
|
| • |
|
The website of the Vaccine Adverse Event Reporting System has been added. |
|
|
|
| • |
|
A new URL for the National Vaccine Injury Compensation Program has been added. |
|
|
|
| POLISH TRANSLATION OF THE MARCH 31, 2000 MENINGOCOCCAL VIS |
|
|
|
|
|
|
| This translation does not contain the following
CDC updates: |
|
| • |
|
The Guillain-Barre Syndrome (second bullet just above section 6) was changed slightly: "a few" was replaced by "some" to reflect the additional cases that were reported. |
|
|
|
| • |
|
Section 5: Under severe problems, CDC added information about a possible connection to Guillain-Barre Syndrome. |
|
|
|
| • |
|
Section 1: CDC changed the words to say, "Of those who live, another 11%-19% lose their arms or legs..." |
|
|
|
| • |
|
Section 3: There are new recommendations for MCV4. CDC has added that meningococcal vaccine is recommended for college freshman living in dormitories and microbiologists who are routinely exposed to meningococcal bacteria. |
|
|
|
| • |
|
Section 4: It says MCV4 is a new vaccine that has not been studied in pregnant women as much as MPSV4 has. |
|
|
|
| • |
|
Section 5: There is some more information about MCV4. |
|
|
|
|
POLISH TRANSLATION OF THE JANUARY 1, 2000 POLIO - IPV VIS |
|
|
|
|
|
|
| This translation does not contain the following
CDC update: |
|
| • |
|
This edition does not differ significantly from the previous edition, particularly with regard to contraindications and
adverse events. CDC encourages use of a new VIS upon publication; however, existing stocks of the previous edition may be
used up. |
|
|
|
| POLISH TRANSLATION OF THE JUNE 10, 1994 TD VIS |
|
|
|
|
| *Td VIS was replaced on November 18, 2008 with the Td/Tdap VIS |
|
| For the out-of-date Td translation, visit the Td/Tdap VIS section |
A-Z
